Your browser doesn't support javascript.
loading
UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.
Madreiter-Sokolowski, Corina T; Gyorffy, Balázs; Klec, Christiane; Sokolowski, Armin A; Rost, Rene; Waldeck-Weiermair, Markus; Malli, Roland; Graier, Wolfgang F.
Affiliation
  • Madreiter-Sokolowski CT; Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
  • Gyorffy B; MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary.
  • Klec C; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Sokolowski AA; Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
  • Rost R; Dentistry and Maxillofacial Surgery, Medical University of Graz, Graz, Austria.
  • Waldeck-Weiermair M; Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
  • Malli R; Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
  • Graier WF; Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Oncotarget ; 8(46): 80278-80285, 2017 Oct 06.
Article in En | MEDLINE | ID: mdl-29113301
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Country of publication: